See the company profile for BioCryst Pharmaceuticals, Inc. (BCRX) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their compensation.

BCRX Price Target and Analyst Ratings (BioCryst ... Nov 06, 2019 · 8 Wall Street analysts have issued ratings and price targets for BioCryst Pharmaceuticals in the last 12 months. Their average twelve-month price target is $8.93, suggesting that the stock has a possible upside of 371.16%. The high price target for BCRX is … BioCryst: Much At Stake In Next Phase I Results Of BCX9930 ... Oct 07, 2019 · In my previous article on Biocryst (NASDAQ:BCRX) I explained the reasons why, in my opinion, the market negatively overreacted to the positive …

BioCryst Pharmaceuticals, Inc.'s stock rating is based on fundamental analysis. Don't miss BCRX stock next rating changes

BioCryst Pharmaceuticals (BCRX) Stock: Gaining On Japanese ... Apr 03, 2017 · Where do you think BCRX is headed moving forward? Join the discussion in the comments below or on StockTwits! Never Miss The News Again. Do you want real-time, actionable news delivered to … Trade App ST Invest LLC (d/b/a Trade App) is a wholly owned subsidiary of StockTwits, Inc. Securities products and services offered to self-directed investors through ST Invest LLC. ST Invest LLC is a member of the Financial Industry Regulatory Authority (FINRA) BioCryst Pharmaceuticals, Inc. (BCRX) Stock Charts Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! BCRX stock: BioCryst Pharmaceuticals, Inc.

Mar 5, 2020 BioCryst (BCRX) delivered earnings and revenue surprises of 92.00% and 230.49%, respectively, for the quarter ended December 2019.

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Charts Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! BCRX stock: BioCryst Pharmaceuticals, Inc. BioCryst Pharmaceuticals, Inc.'s stock rating is based on fundamental analysis. Don't miss BCRX stock next rating changes BioCryst Pharmaceuticals Shares Outstanding | BCRX In depth view into BioCryst Pharmaceuticals Shares Outstanding including historical data from 1994, charts, stats and industry comps.

Oct 1, 2014 BioCryst Pharmaceuticals (BCRX), Inovio Pharmaceuticals (INO) and a product to monetize right now," Stocktwits user aaoomomo wrote.

BCRX Stock Summary. Of note is the ratio of Biocryst Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; merely 12.98% of US stocks have a lower such ratio. BCRX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 99.59% of US stocks. BCRX Price Target and Analyst Ratings (BioCryst ...

BioCryst Pharmaceuticals, Inc., a biotechnology company, engages in the design, optimization, and development of drugs that block key enzymes involved in cancer, viral …

Apr 01, 2020 · BioCryst Pharmaceuticals, Inc. (BCRX) announced that the European Medicines Agency has validated its marketing authorization application submission for approval of oral, StockTwits Read live tweets from the financial and investing community about the stock you're interested in. BCRX Stock Price & Charts | BioCryst Pharmaceuticals In depth view into BCRX (BioCryst Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials.

Trade App ST Invest LLC (d/b/a Trade App) is a wholly owned subsidiary of StockTwits, Inc. Securities products and services offered to self-directed investors through ST Invest LLC. ST Invest LLC is a member of the Financial Industry Regulatory Authority (FINRA) BioCryst Pharmaceuticals, Inc. (BCRX) Stock Charts Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!